Two experimental coronavirus vaccines has been approved by China to battle and prevent a second wave of COVID-19 in the country.
The experimental vaccines are being developed by a Beijing-based unit of Sinovac Biotech and the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group, the state news agency, Xinhua reported.
According to reports, China’s National Health Commission also confirmed the trials will go ahead.
“We can confirm now that three particular vaccines are being tested in China, and the National Health Commission has said it will have to clear a number of conditions before they can enable mass production of the vaccines globally,” Hong Kong based Sarah Clarke said to AlJazeera on Tuesday.
As of Tuesday, China reported 82,249 coronavirus cases and 3,341 deaths.
World's 1st inactivated #coronavirus vaccine has been approved for clinical trial on April 12 in China. (People's Daily) #Covid_19 pic.twitter.com/YIMixHUrGw
— China Daily (@ChinaDaily) April 14, 2020
Good news! China approved clinical trials for two types of inactivated #vaccines for #COVID_19 on Tuesday. pic.twitter.com/4nx41wiN20
— China Daily (@ChinaDaily) April 14, 2020
“A total of 500 people signed up to volunteer for that in the first phase, which looked at the safety of this vaccine, and the second phase has now introduced a placebo control group,” she added.
